Omeros (OMER) Times Interest Earned (2010 - 2026)
Omeros (OMER) reported Times Interest Earned of -$2.96 for Q1 2026, up 13.63% on a YoY basis from -$2.6 in Q1 2025, and up 11.31% sequentially from -$3.33 in Q4 2025.
Omeros (OMER) Times Interest Earned (2010 - 2026) Analysis & Trends
Omeros (OMER) has 17 years of Times Interest Earned data on file, last reported at -$2.96 in Q1 2026.
- For the quarter ending Q1 2026, Times Interest Earned rose 13.63% year-over-year to -$2.96; the trailing twelve-month figure through Mar 2026 stood at -$2.15 (up 31.66% YoY), and the FY2025 full-year result was -$0.67, up 77.51% from the prior year.
- Times Interest Earned improved to -$2.96 in Q1 2026, from -$3.33 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of $3.37 in Q4 2022 to a low of -$10.29 in Q3 2022.
- A 5-year average of -$4.1 and a median of -$4.5 in 2023 frame the typical range for Times Interest Earned.
- Peak annual rise in Times Interest Earned reached 197.17% in 2022, while the deepest fall reached 494.52% in 2022.
- Tracing OMER's Times Interest Earned over 5 years: stood at $3.37 in 2022, then sank by 155.97% to -$1.89 in 2023, then rose by 26.89% to -$1.38 in 2024, then sank by 141.46% to -$3.33 in 2025, then increased by 11.31% to -$2.96 in 2026.
- Business Quant data shows OMER's Times Interest Earned at -$2.96 in Q1 2026, -$3.33 in Q4 2025, and -$1.22 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -157.58 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 7.60 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -0.38 |
| 10 | Omeros | 707.67 Mn | 707.67 Mn | 9.31 Mn | -2.96 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.96 |
| Dec 31, 2025 | -3.33 |
| Sep 30, 2025 | -1.22 |
| Jun 30, 2025 | -2.51 |
| Mar 31, 2025 | -3.42 |
| Dec 31, 2024 | -1.38 |
| Sep 30, 2024 | -5.74 |
| Jun 30, 2024 | -6.42 |
| Mar 31, 2024 | -4.74 |
| Dec 31, 2023 | -1.89 |
| Sep 30, 2023 | -6.08 |
| Jun 30, 2023 | -5.16 |
| Mar 31, 2023 | -4.50 |
| Dec 31, 2022 | 3.37 |
| Sep 30, 2022 | -10.29 |
| Jun 30, 2022 | -7.60 |
| Mar 31, 2022 | -5.87 |
| Dec 31, 2021 | -3.47 |
| Sep 30, 2021 | -1.73 |
| Jun 30, 2021 | -1.35 |